ArterisAIP
AIP logo
Fair Value
US$35
Share price05 Jun
US$29.7814.9% undervalued intrinsic discount
Loading
1Y220.22%
7D-0.33%

Trade Tensions And Risks Will Limit Markets Yet Yield Hope

Analyst Low Target compiles bearish analysts opinions to create narratives which represent one standard deviation below the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
09 Aug 25
Updated
05 Jun 26
Views
23
Not Invested

Last Update 05 Jun 26

AIP: Data Center AI Royalties Will Test Elevated Multiple And Margin Discipline

Analysts have lifted their average price target on Arteris from $20 to a range of $35 to $40. They cite a recent beat and raise quarter, stronger data center and AI related licensing activity, and expectations for earlier and higher royalty contributions compared with automotive licenses.

Analyst Commentary

Recent research updates have centered on Arteris' strong quarterly print and a reset of expectations around its exposure to data center and AI licensing. Across the board, analysts pointed to the recent beat relative to prior expectations and to raised guidance as key reasons for lifting targets into the mid to high US$30s.

A common thread in the commentary is the shift in Arteris' mix toward data center and AI related licenses. Several firms highlighted that these licenses are now the largest vertical for the company, with the potential for earlier royalty realization and higher average selling prices compared with automotive related contracts. This is seen as an important driver for future royalty contribution timing.

At the same time, analysts also flagged the improved royalty trends tied to greater data center exposure, linking this to industry wide demand for faster data movement in AI chips. The view is that the underlying technology is well positioned for workloads that require high bandwidth connections and efficient on chip communication.

However, not all commentary was unreservedly positive. One firm, which maintains a Hold rating despite raising its target to US$35, pointed to rising spending and the need for better clarity around profitability. This adds a layer of caution around how the company balances growth investments with the path to sustained earnings.

For readers, the key takeaway is that while the Street has shifted price targets higher following the recent quarter, there is still active debate around the durability of demand, royalty timing, and how the spending profile affects long term margin potential.

Bearish Takeaways

  • Bearish analysts highlight rising operating spending and want more visibility on when this investment translates into sustainable profitability, which introduces execution risk around margins.
  • The reliance on data center and AI related licenses for earlier and higher royalty contributions could create concentration risk if demand patterns or project timing change.
  • Some cautious views point to the gap between upgraded targets and current fundamentals, suggesting that expectations may already price in strong growth in royalties and licensing activity.
  • Hold level ratings, even after target increases, signal that some bearish analysts still see an uneven risk and reward profile as the company works through higher spending and profitability questions.

What’s in the News

  • Arteris outlined a long term plan targeting US$250 million in revenue by 2030, anchored on growth in semiconductor system IP tied to AI, data center, and chiplet design trends. The company is also aiming for free cash flow positivity and non GAAP profitability over time. (Source: Arteris Targets $250M Revenue by 2030 Through AI, Data Center, and Chiplet Growth)
  • The company highlighted that its data center business is expected to be a key growth contributor within its system IP portfolio. This reflects the increasing role of chiplets in AI and data center architectures. (Source: Arteris Targets $250M Revenue by 2030 Through AI, Data Center, and Chiplet Growth)
  • Following fiscal Q1 results, several analysts raised price targets on Arteris and cited stronger AI chip data movement demand. They also pointed to the need for more visibility on profitability given higher spending. (Source: Here’s What the Street is Saying About Arteris, Inc. (AIP))
  • Arteris provided revenue guidance for Q2 2026 of US$23.0 million to US$24.0 million and for full year 2026 of US$91.0 million to US$95.0 million. This sets reference points for investors tracking execution against its longer term goals. (Source: Company guidance)
  • The company announced that Chief Financial Officer Nicholas B. Hawkins plans to retire effective August 31, 2026, for family health reasons. He will remain as an advisor during the transition while the board conducts a search for a new CFO. (Source: Executive changes filing)

Valuation Changes

  • Fair Value: unchanged at $35.0, indicating no shift in the modeled intrinsic value per share in this update.
  • Discount Rate: risen slightly from 8.48% to 8.61%, implying a modestly higher required return in the valuation framework.
  • Revenue Growth: revised slightly higher from 24.35% to 24.73%, reflecting a small uplift in projected top line expansion in dollar terms.
  • Net Profit Margin: edged down from 12.42% to 12.11%, pointing to slightly lower expected profitability on future dollar revenues.
  • Future P/E: moved up modestly from 136.14x to 138.84x, implying a slightly richer multiple on projected earnings in the model.
2 viewsusers have viewed this narrative update

Key Takeaways

  • Revenue growth and market share are threatened by geopolitical shifts, industry consolidation, and increased international competition as countries localize semiconductor IP development.
  • High dependency on key clients, rising R&D expenses, and pressures from open-source standards could limit pricing power, margin expansion, and long-term earnings stability.
  • Persistent losses, high operating expenses, customer concentration, and competitive threats all threaten Arteris's ability to achieve sustainable profitability and consistent revenue growth.

Catalysts

About Arteris
    Provides semiconductor system intellectual property solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East.
What are the underlying business or industry changes driving this perspective?
  • While Arteris is seeing strong demand from secular growth in AI/ML-driven computing and an expanding shift toward chiplet-based semiconductor architectures, rising global trade tensions and technology localization initiatives may lead to more countries developing in-house chip IP, potentially decreasing Arteris's addressable international market and putting future revenue growth at risk.
  • Despite a record increase in remaining performance obligations and multi-year licensing wins from Tier 1 customers like AMD, Arteris's ongoing dependence on a handful of major clients, combined with the cyclical nature of semiconductor end-markets, leaves the company exposed to significant revenue concentration and future earnings volatility if any large customer reduces purchases or changes direction.
  • Although Arteris continues to invest heavily in R&D to expand its IP portfolio and capitalize on industry trends in edge computing and IoT, elevated R&D costs-now outpacing revenue growth-may compress net margins over the long run, particularly if margin expansion from new products such as FlexGen does not materialize as quickly as anticipated.
  • While industry-wide momentum for heterogeneous integration and demands for scalable, flexible NoC architectures should support Arteris's market position, the intensifying competition from larger, integrated EDA/IP providers and ongoing industry consolidation could undermine Arteris's pricing power and decrease renewal rates, ultimately impacting revenue growth and gross margin stability.
  • Even as customers accelerate the outsourcing of sophisticated SoC and chiplet design to Arteris, the increasing prevalence of open-source hardware/IP standards could limit the company's ability to command premium pricing, potentially capping long-term top-line growth and dampening the high-margin royalty streams that underpin future earnings stability.
Arteris Earnings and Revenue Growth

Arteris Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • This narrative explores a more pessimistic perspective on Arteris compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
  • The bearish analysts are assuming Arteris's revenue will grow by 24.7% annually over the next 3 years.
  • The bearish analysts are not forecasting that Arteris will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Arteris's profit margin will increase from -44.9% to the average US Software industry of 12.1% in 3 years.
  • If Arteris's profit margin were to converge on the industry average, you could expect earnings to reach $18.1 million (and earnings per share of $0.32) by about June 2029, up from -$34.6 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $26.3 million in earnings, and the most bearish expecting $-6.6 million.
  • In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 140.2x on those 2029 earnings, up from -49.7x today. This future PE is greater than the current PE for the US Software industry at 29.2x.
  • The bearish analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.61%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Arteris's ongoing non-GAAP and GAAP net losses, combined with negative free cash flow in the most recent quarter, raise concerns about the company's ability to turn scale and sales momentum into sustainable profitability, which threatens net margins and future earnings.
  • The company is experiencing elevated operating expenses, especially in R&D and field engineering, and its outlook indicates that these costs will remain high in order to maintain product innovation, creating risk that profit margins will continue to be pressured if revenue growth stalls or lags behind expenses.
  • High customer concentration remains a risk, as the financial update highlights whale deals and large, multi-license contracts with partners like AMD, suggesting that any reduction in business from a few key customers could drive substantial revenue declines and increase earnings volatility.
  • The text mentions intensifying competition and the need for Arteris's solutions to coexist or integrate with leading customers' internal interconnect technologies (such as AMD's Infinity Fabric), revealing a risk that major customers may continue investing in or shift back toward in-house solutions, which could diminish Arteris's market share and depress future revenues.
  • While the company reports growing demand and expanding relationships, global economic uncertainty, foreign exchange rate fluctuations-particularly the weakening dollar driving higher OpEx-and potential macro shocks may slow customer investment cycles or delay projects, impacting revenue growth and reducing cash flow predictability.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The assumed bearish price target for Arteris is $35.0, which represents up to two standard deviations below the consensus price target of $37.75. This valuation is based on what can be assumed as the expectations of Arteris's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $40.0, and the most bearish reporting a price target of just $35.0.
  • In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be $149.4 million, earnings will come to $18.1 million, and it would be trading on a PE ratio of 140.2x, assuming you use a discount rate of 8.6%.
  • Given the current share price of $37.19, the analyst price target of $35.0 is 6.3% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Arteris?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

US$35
vs US$29.7814.9% undervalued intrinsic discount
PastFuture-36m149m2019202120232025202620272029Revenue US$149.4mEarnings US$18.1m
24.7%
Revenue growth
12.1%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Arteris

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Flawless balance sheet with slight risk.

Market capUS$1.5b
PB21.6x
Estimated Growth22.6%
Dividend YieldN/A
Full analysis

CEO & management

Karel Janac
CEO
5.4yrs
CEO Tenure

Provides semiconductor system intellectual property (IP) solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East.